BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 35231661)

  • 1. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
    Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
    J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
    Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
    Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary proteomics for oral cancer biomarker discovery.
    Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
    Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation.
    Ni YH; Ding L; Hu QG; Hua ZC
    Proteomics Clin Appl; 2015 Feb; 9(1-2):86-97. PubMed ID: 25431113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Proteomic Analysis of Non-Tobacco Associated Oral Squamous Cell Carcinoma Reveals Deregulation of Cytoskeletal and Apoptotic Proteins.
    T A S; Narayan M; Krishnan R; Thayalan D; Gunasekaran N; S P
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4285-4292. PubMed ID: 36580011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
    Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
    Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Cargo of Salivary Small Extracellular Vesicles as Potential Functional Signature of Oral Squamous Cell Carcinoma.
    Fontana S; Mauceri R; Novara ME; Alessandro R; Campisi G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner.
    Dickinson A; Saraswat M; Mäkitie A; Silén R; Hagström J; Haglund C; Joenväärä S; Silén S
    Oral Oncol; 2018 Nov; 86():206-215. PubMed ID: 30409303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.
    Jancsik VA; Gelencser G; Maasz G; Schmidt J; Molnar GA; Wittmann I; Olasz L; Mark L
    Pathol Oncol Res; 2014 Jul; 20(3):591-5. PubMed ID: 24343817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.
    Chi LM; Lee CW; Chang KP; Hao SP; Lee HM; Liang Y; Hsueh C; Yu CJ; Lee IN; Chang YJ; Lee SY; Yeh YM; Chang YS; Chien KY; Yu JS
    Mol Cell Proteomics; 2009 Jul; 8(7):1453-74. PubMed ID: 19297561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
    Hsu CW; Yu JS; Peng PH; Liu SC; Chang YS; Chang KP; Wu CC
    J Proteome Res; 2014 Nov; 13(11):4796-807. PubMed ID: 24708169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Salivary Proteomic Markers of Oral Squamous Cell Carcinoma.
    Gallo C; Ciavarella D; Santarelli A; Ranieri E; Colella G; Lo Muzio L; Lo Russo L
    Cancer Genomics Proteomics; 2016; 13(1):55-61. PubMed ID: 26708599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine 2-hydroxyisobutyrylation proteomics reveals protein modification alteration in the actin cytoskeleton pathway of oral squamous cell carcinoma.
    Zhang Z; Xie H; Zuo W; Tang J; Zeng Z; Cai W; Lai L; Lu Y; Shen L; Dong X; Yin L; Tang D; Dai Y
    J Proteomics; 2021 Oct; 249():104371. PubMed ID: 34500091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of lysine acetylome of oral squamous cell carcinoma by label-free quantitative proteomics.
    Dong J; He J; Zhang Z; Zhang W; Li Y; Li D; Xie H; Zuo W; Tang J; Zeng Z; Cai W; Lai L; Yun M; Shen L; Yin L; Tang D; Dai Y
    J Proteomics; 2022 Jun; 262():104598. PubMed ID: 35489685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
    Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
    J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered protein profile of plasma extracellular vesicles in oral squamous cell carcinoma development.
    Xu K; Liu L; Wu K; Zhang M; Xie R; Li R; Zhao M; Yang H; Duan N; Wang X; Wang W
    J Proteomics; 2022 Jan; 251():104422. PubMed ID: 34775099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.
    Marimuthu A; Chavan S; Sathe G; Sahasrabuddhe NA; Srikanth SM; Renuse S; Ahmad S; Radhakrishnan A; Barbhuiya MA; Kumar RV; Harsha HC; Sidransky D; Califano J; Pandey A; Chatterjee A
    Biochim Biophys Acta; 2013 Nov; 1834(11):2308-16. PubMed ID: 23665456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.